COVID-19
FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests
The agency said the issue could be related to current mixing parameters of the PCR reaction mixture resulting in overflow in wells of the reagent tray.
ConcertAI Growing Presence in Real-World Data Analytics Space With Focus on Diversifying Trials
Premium
The company is using real-word data and machine-learning algorithms to help customers identify and address gaps in precision medicine access and research.
Tennessee's COVID-19 Sequencing
The Tennessean reports that a state lab there can now run its own genome sequencing analyses of SARS-CoV-2 samples.
Prenetics to Go Public Through SPAC
Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.
Thermo Fisher Scientific Receives CE Mark for TaqPath COVID-19 RNase P 2.0 Testing Kit
The assay, which received FDA Emergency Use Authorization in July, is designed to compensate for current and future COVID-19 viral mutations.
Sep 13, 2021
Sep 9, 2021
Sep 7, 2021
Sep 7, 2021
Sep 7, 2021
Seqera Labs Raises $5.5M in Seed Funding
Sep 5, 2021
UK Government Investigates COVID-19 Testing Firm
Sep 2, 2021
Sep 2, 2021
Cue Health Files for IPO for up to $100M
Sep 2, 2021
Biocartis H1 Revenues up 31 Percent
Sep 1, 2021